Abstract
In people aged 65 years or older, age-related macular degeneration (AMD) causes more visual impairment and blindness than any other condition. At the time of publication of this paper, there were a few medical and surgical interventions being studied, but none had been found to be effective. Observational studies have suggested that antioxidants and zinc might slow age-related macular degeneration and the visual impairments it causes.
A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss. (2001). Archives of Ophthalmology, 119(10), 1417. doi: 10.1001/archopht.119.10.1417.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol. 2001;119(10):1417. https://doi.org/10.1001/archopht.119.10.1417.
Bressler NM, et al. Potential public health impact of age-related eye disease study results. Arch Ophthalmol. 2003;121(11):1621. https://doi.org/10.1001/archopht.121.11.1621.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sprogell, A. (2023). Antioxidants and Macular Degeneration-2001. In: Russell, J., Skolnik, N.S. (eds) Top Articles in Primary Care. Springer, Cham. https://doi.org/10.1007/978-3-031-25620-2_61
Download citation
DOI: https://doi.org/10.1007/978-3-031-25620-2_61
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-25619-6
Online ISBN: 978-3-031-25620-2
eBook Packages: MedicineMedicine (R0)